Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model

International Journal of Epidemiology

Volumn 29, Issue 3, 2000, Pages 565-572

  Hendriks, Jan C P ^a,e   Craib, Kevin J P ^b   Veugelers, Paul J ^c   Van Druten, Hans A P ^f   Coutinho, Roel A ^a   Schechter, Martin T ^d   Van Griensven, Godfried J P ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b ST PAUL S HOSPITAL   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f NONE

Author keywords

CD4 count; HIV disease progression; Homosexual men; Incubation period distribution; Markov model; Trends in waiting time

Indexed keywords

ARTICLE; CANADA; COHORT ANALYSIS; DEATH; DISEASE COURSE; DISEASE MODEL; FOLLOW UP; GROWTH; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; PRIORITY JOURNAL; PROBABILITY; REGISTER; SURVIVAL; T LYMPHOCYTE;

EID: 0033948814     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/intjepid/29.3.565     Document Type: Article

References (23)

1. Hessol NA, Koblin BA, Van Griensven GJP et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in Hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994; 139:1077-87.
2. Veugelers PJ, Page KA, Tindall B et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter study. Am J Epidemiol 1994;140:747-57.
3. Muñoz A, Xu J. Models for the incubation period of AIDS and variations according to age and period. Stat Med 1996;15:2459-73.
4. Keet IPM, Veugelers PJ, Koot M et al. Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1989. AIDS 1996;10:1601-02.
5. Van Griensven GJP, Boucher EC, Roos M, Coutinho RA. Expansion of the AIDS case definition. Lancet 1991;338:1011-12.
6. Schechter MT, Craib KJP, Le TN et al. Influence of zidovudine on progression to AIDS in cohort studies. Lancet 1989;1:1026-27.
7. Hoover DR. The effects of long term Zidovudine therapy and Pneumotystis carinii prophylaxis on HIV disease. Drug 1995;49:20-36.
8. Veugelers PJ, Strathdee SA, Moss AR et al. Is the Human immuno-deficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the tricontinental seroconverter study. Epidemiology 1995;6:382-86.
9. 6/1 but free of AIDS-defining clinical disease. AIDS 1994;8:1577-83.
10. Muñoz A, Sabin CA, Phillips AN. The incubation period of AIDS. AIDS 1997;11(Suppl.A):S69-S76.
11. Simons P, Muylderman G, Lacor P, Zissis G, Lauwers S. False-negative HIV viral load in AIDS patients. AIDS 1997;11:1783-84.
12. Centers for Disease Control: Revision of the CDC surveillance case definition of acquired immnunodeficiency syndrome. MMWR 1987; 36:35-15S.
13. Longini IM, Clark WS, Karon JM. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based-cohort. Am J Epidemiol 1993;137: 1229-40.
14. Hendriks JCM, Satten GA, Longini IM et al. Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men. AIDS 1996;10:649-56.
15. Satten GA, Longini IM Jr. Markov chains with measurement error: estimating the 'true' course of a marker of HIV disease progression. Appl Stat 1996;45:275-311.
16. Hendriks JCM, Satten GA, van Ameijden EJC, van Diuten JAM, Coutinho RA, van Griensven GJP. The incubation period to AIDS among injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis. AIDS 1998;12: 1537-44.
17. Longini IM, Clark WS, Byers RH et al. Statistical analysis of the stages of HIV infection using a Markov model. Stat Med 1989;8: 831-43.
18. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993.
19. Graham NHM, Zeger SL, Park LP et al. The effects on survival of early treatment of human immunodeficiency virus infection. New Engl J Med 1992;326:1037-42.
20. Veugelers PJ, Cornelisse PGA, Craib KJP et al. Models of survival in HIV infection and their use in the quantification of treatment benefits. Am J Epidemiol 1998;148:487-96.
21. Taylor JMG, Kuo JM, Detels R. Is the incubation period of AIDS lengthening? J Acquir Immune Defic Syndr 1991;4:69-75.
22. O'Brien TR, Hoover DR, Rosenberg PS et al. Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected man with known dates of seroconversion. Am J Epidemiol 1995;142:636-42.
23. Galai N, Cozzi Lepri A, Vlahov D, Pezotti P, Sinicco A, Rezza G for the Human Immunodeficiency Virus Italian Seroconversion Study. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. Am J Epidemiol 1995;143:278-82.